The role of quantitative TFPI2 methylation as a novel serum diagnostic and prognostic marker in hepatopancreaticobiliary cancers

Simple item page
dc.contributor.authorNeslihan, E
dc.contributor.authorElmas, K
dc.contributor.authorSeda, ÖB
dc.contributor.authorTahir, B
dc.contributor.authorEmre, G
dc.contributor.authorHakan, YM
dc.contributor.authorCeren, EUB
dc.contributor.authorGokcen, TA
dc.contributor.authorMehmet, K
dc.date.accessioned2024-07-18T12:05:04Z
dc.date.available2024-07-18T12:05:04Z
dc.identifier.issn0923-7534
dc.identifier.other1569-8041
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/9513
dc.language.isoEnglish
dc.publisherOXFORD UNIV PRESS
dc.titleThe role of quantitative TFPI2 methylation as a novel serum diagnostic and prognostic marker in hepatopancreaticobiliary cancers
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu